TY - JOUR
T1 - Human endogenous retroviruses env gene expression and long terminal repeat methylation in colorectal cancer patients
AU - Dolci, Maria
AU - Favero, Chiara
AU - Tarantini, Letizia
AU - Villani, Sonia
AU - Bregni, Marco
AU - Signorini, Lucia
AU - Della Valle, Alberto
AU - Crivelli, Filippo
AU - D’Alessandro, Sarah
AU - Ferrante, Pasquale
AU - Bollati, Valentina
AU - Delbue, Serena
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Human endogenous retroviruses (HERV) are remnants of exogenous retroviral infections, representing 8% of the human genome. Their regulation is based on the DNA methylation of promoters, the long terminal repeats (LTRs). Transcripts from HERV have been associated with cancers, but reports concerning HERV expression in colorectal cancer remain sporadic. Sixty-three patients with advanced stages of colorectal cancer were enrolled in this study. The expressions of HERV env gene, and HERV-H, -K, -R and -P LTRs and Alu, LINE-1 methylation levels, were investigated in the tumor, normal adjacent tissues, and, where possible, blood and plasmatic extracellular vesicles (EVs). Associations among HERV env expression, methylation status and clinical characteristics were evaluated. No differences were observed in HERV env gene expression levels among the clinical specimens, while Alu, LINE-1, HERV-H and -K LTRs were demethylated in the tumor compared to the normal adjacent tissues (p < 0.05).The HERV env gene was expressed in the EVs at of 54% (-H), 38% (-K), 31% (-R) patients. Association was not found between HERV env expression and LTR methylation, but significant higher expression of HERV-P and -R env was found in tumor tissues arising from the right colon. Our findings do not demonstrate significant overexpression of the studied HERV in colorectal cancer, but their association with tumor localization and specificity of the changes in DNA methylation of retroelements are shown. HERV sequences were packaged in the EVs and might be transferred from one cell to another.
AB - Human endogenous retroviruses (HERV) are remnants of exogenous retroviral infections, representing 8% of the human genome. Their regulation is based on the DNA methylation of promoters, the long terminal repeats (LTRs). Transcripts from HERV have been associated with cancers, but reports concerning HERV expression in colorectal cancer remain sporadic. Sixty-three patients with advanced stages of colorectal cancer were enrolled in this study. The expressions of HERV env gene, and HERV-H, -K, -R and -P LTRs and Alu, LINE-1 methylation levels, were investigated in the tumor, normal adjacent tissues, and, where possible, blood and plasmatic extracellular vesicles (EVs). Associations among HERV env expression, methylation status and clinical characteristics were evaluated. No differences were observed in HERV env gene expression levels among the clinical specimens, while Alu, LINE-1, HERV-H and -K LTRs were demethylated in the tumor compared to the normal adjacent tissues (p < 0.05).The HERV env gene was expressed in the EVs at of 54% (-H), 38% (-K), 31% (-R) patients. Association was not found between HERV env expression and LTR methylation, but significant higher expression of HERV-P and -R env was found in tumor tissues arising from the right colon. Our findings do not demonstrate significant overexpression of the studied HERV in colorectal cancer, but their association with tumor localization and specificity of the changes in DNA methylation of retroelements are shown. HERV sequences were packaged in the EVs and might be transferred from one cell to another.
KW - Colon cancer
KW - Gene expression
KW - Human endogenous retrovirus
KW - Methylation
KW - Microvesicles
UR - http://www.scopus.com/inward/record.url?scp=85079439104&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079439104&partnerID=8YFLogxK
U2 - 10.1007/s00430-020-00662-6
DO - 10.1007/s00430-020-00662-6
M3 - Article
C2 - 32040616
AN - SCOPUS:85079439104
SN - 0300-8584
VL - 209
SP - 189
EP - 199
JO - Medical Microbiology and Immunology
JF - Medical Microbiology and Immunology
IS - 2
ER -